Montanide™ ISA 51 VG is composed of a mineral oil combined with a surfactant system designed to make a water in oil emulsion.
Seppic ensures a complete GMP process and manufactures this adjuvant under aseptic conditions in a pharmaceutical establishment.
Montanide™ ISA 51 VG has been used in about 400 clinical trials from phase I to phase III, and is currently used in numerous studies.
Montanide™ ISA 51 VG is in the composition of a therapeutic vaccine approved for the treatment of non-small cell lung cancer in seven countries.
Chemistry |
Mineral oil & Surfactant |
Regulatory compliance |
GMP |
Administration route |
Subcutaneous
Intradermal
Intramuscular |
Market applications |
Human vaccines |
Functions |
Vaccine adjuvant |
Characteristics |
Oily adjuvant
Ready to emulsify |
Packaging |
Sterile vials
Non sterile bulk |